Boston Oncology Partners with China's Xuanzhu Biopharmaceutical for Cancer Drug Deal

Boston Oncology has entered into a cancer drug deal with China's Xuanzhu Biopharmaceutical. This collaboration aims to advance the development and distribution of new treatments for cancer patients.